HistoIndex Announces Appointment of Robert Davidson as Chief Financial Officer
HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announces the appointment of Mr. Robert Davidson as Chief Financial Officer. Robert is a chartered accountant and joins the HistoIndex senior management with more than 20 years of experience in strategic finance, operations management and corporate governance including previous board-level directorship.
Mr. Robert Davidson joins HistoIndex as the Chief Financial Officer. Picture Credits: Robert Davidson/HistoIndex
In his previous tenures in the private and public sectors, Robert led finance teams of various sizes and executed critical functions such as corporate and tax group restructuring, risk management and improvements on financial reporting and internal operations. He fostered strong relationships with both debt and equity providers, notably with banking industry counterparts and agencies, which led to his facilitation of successful investor funding and lucrative joint ventures.
Says Dr. Gideon Ho, Chief Executive Officer of HistoIndex, “On behalf of HistoIndex, I warmly welcome Robert to our team, and we look forward to our company’s continued growth with his contributions. Robert has a mutual passion in healthcare innovation and brings with him a wealth of experience in financial leadership across a variety of industries. I trust that his diverse expertise will further reinforce our business strategies in pursuit of new corporate interests.”
Says Robert on his new beginning at HistoIndex, “It is an honour to be appointed as CFO, as I am inspired by the dedication shown by the exceptional team at HistoIndex in making a difference in the drug development and clinical diagnostics space for better patient outcomes. I believe that my experience along with my growing knowledge of the company’s proprietary technology and business model makes me well aligned with the vision of this company. I am eager to work with Gideon and the HistoIndex team in achieving great success.”
From a healthcare-related industry, Robert has years of experience as a regulator and Director of Finance and Reporting at Monitor, the sector regulator of England’s National Health Service (NHS) Foundation Trust Hospitals. He also has experience of capital markets and private equity funding from his time as a Corporate Finance Director at the renowned accountancy and financial services firm, BDO LLP, London, and corporate governance expertise from a two-year secondment at the HM Treasury. In addition, Robert is a Fellow of both the Institute of Chartered Accountants in England and Wales, and the Chartered Institute for Securities and Investment.